| Regeneron Pharmaceuticals, Inc. |
Level II |
28 | 93 |
$156,550 |
| Two Sigma Investments, LP |
Level I |
13 | 13 |
$220,000 |
| NOVARTIS PHARMACEUTICALS CORPORATION |
Level II |
12 | 12 |
$112,965 |
| Ernst & Young U.S. LLP |
Level II |
11 | 11 |
$151,743 |
| Ernst & Young U.S. LLP |
Level III |
11 | 11 |
$186,883 |
| Merck Sharp & Dohme LLC |
Level II |
11 | 11 |
$117,000 |
| Merck Sharp & Dohme LLC |
Level III |
8 | 8 |
$144,373 |
| Two Sigma Investments, LP |
Level IV |
8 | 8 |
$252,500 |
| HRT Research LLC |
Level IV |
7 | 7 |
$185,000 |
| DeltaMed Solutions Inc. |
Level I |
6 | 6 |
$83,672 |
| Meta Platforms, Inc |
Level IV |
6 | 6 |
$237,271 |
| Regeneron Pharmaceuticals, Inc. |
Level III |
6 | 6 |
$190,453 |
| WorldQuant, LLC |
Level II |
6 | 6 |
$120,000 |
| DAIICHI SANKYO, INC. |
Level II |
5 | 5 |
$145,000 |
| Eli Lilly and Company |
Level II |
5 | 5 |
$133,784 |
| ExlService.com, LLC |
Level II |
5 | 41 |
$112,965 |
| JPMorgan Chase & Co. |
Level IV |
5 | 5 |
$203,000 |
| Morgan Stanley & Co., LLC |
Level III |
5 | 5 |
$225,000 |
| TechData Service Company, LLC |
Level I |
5 | 5 |
$92,600 |
| Two Sigma Investments, LP |
Level II |
5 | 5 |
$240,000 |
| Albert Einstein College of Medicine |
Level I |
4 | 4 |
$77,405 |
| Columbia University |
Level I |
4 | 4 |
$77,457 |
| Ernst & Young U.S. LLP |
Level I |
4 | 4 |
$86,008 |
| IQVIA RDS Inc. |
Level III |
4 | 4 |
$170,000 |
| Morgan Stanley & Co., LLC |
Level II |
4 | 4 |
$212,500 |
| Morgan Stanley Services Group Inc. |
Level III |
4 | 4 |
$191,000 |
| Morgan Stanley Services Group Inc. |
Level IV |
4 | 4 |
$215,000 |
| Aetna Resources LLC |
Level II |
3 | 3 |
$134,173 |
| Aetna Resources LLC |
Level IV |
3 | 3 |
$199,155 |
| Applied Academics, LLC |
Level II |
3 | 3 |
$200,000 |
| Brightech International LLC |
Level II |
3 | 3 |
$116,632 |
| Bristol-Myers Squibb Company |
Level III |
3 | 3 |
$169,950 |
| FOUNTAIN LOGISTICS SOLUTION INC. |
Level I |
3 | 3 |
$144,373 |
| HRT RESEARCH LLC |
Level III |
3 | 3 |
$200,000 |
| JN Data Resolution LLC |
Level I |
3 | 3 |
$91,520 |
| MPG Operations LLC |
Level II |
3 | 3 |
$112,965 |
| NYU Grossman School of Medicine |
Level I |
3 | 3 |
$89,435 |
| Regeneron Genetics Center, LLC |
Level II |
3 | 3 |
$168,701 |
| Regeneron Pharmaceuticals, Inc. |
Level IV |
3 | 12 |
$180,000 |
| Sanofi US Services Inc. |
Level II |
3 | 3 |
$122,250 |
| TechData Service Company, LLC |
Level II |
3 | 3 |
$114,000 |
| Tigermed-BDM Inc |
Level I |
3 | 3 |
$88,949 |
| AbbVie Inc. |
Level IV |
2 | 2 |
$185,500 |
| Admarketplace Inc. |
Level I |
2 | 2 |
$96,700 |
| AG US GROUP SERVICES INC. |
Level I |
2 | 2 |
$95,000 |
| American Express Company |
Level III |
2 | 2 |
$159,046 |
| American Express Travel Related Services Company, Inc. |
Level III |
2 | 2 |
$154,273 |
| APLOMB TECHNOLOGIES INC. |
Level II |
2 | 2 |
$123,500 |
| BANK OF AMERICA N.A. |
Level III |
2 | 2 |
$225,000 |
| Bloomberg L.P. |
Level II |
2 | 2 |
$160,483 |
| Cardiovascular Research Foundation |
Level II |
2 | 2 |
$115,001 |
| Citibank, N.A. |
Level IV |
2 | 2 |
$241,207 |
| Eikon Therapeutics, Inc. |
Level III |
2 | 2 |
$144,373 |
| Ernst & Young U.S. LLP |
Level IV |
2 | 2 |
$201,561 |
| Everest Clinical Research Corporation |
Level III |
2 | 2 |
$144,735 |
| ExlService.com, LLC |
Level IV |
2 | 2 |
$175,781 |
| Icahn School of Medicine at Mount Sinai |
Level I |
2 | 2 |
$79,520 |
| Insurance Services Office, Inc |
Level II |
2 | 2 |
$142,263 |
| INTELENT INC (f.k.a. TESI INC) |
Level II |
2 | 2 |
$113,182 |
| Ipsos MMA, Inc. |
Level II |
2 | 2 |
$140,954 |
| ITCAPS LLC |
Level II |
2 | 2 |
$112,965 |
| JPMorgan Chase & Co. |
Level III |
2 | 2 |
$179,000 |
| LYFT, Inc. |
Level II |
2 | 2 |
$146,500 |
| Maple Health Group, LLC |
Level II |
2 | 2 |
$121,500 |
| Morgan Stanley Services Group Inc. |
Level II |
2 | 2 |
$182,500 |
| New York Society for Relief of Ruptured & Crippled |
Level I |
2 | 2 |
$88,691 |
| NOVARTIS PHARMACEUTICALS CORPORATION |
Level IV |
2 | 2 |
$175,781 |
| NYU Grossman School of Medicine |
Level II |
2 | 2 |
$114,301 |
| Pharmaron US Clinical Services, Inc. |
Level I |
2 | 2 |
$87,758 |
| R Square Technology Inc. |
Level II |
2 | 2 |
$119,500 |
| Regeneron Pharmaceuticals, Inc. |
Level I |
2 | 2 |
$107,579 |
| Standard & Poor's Financial Services LLC |
Level III |
2 | 2 |
$179,713 |
| Symbiance LLC |
Level I |
2 | 2 |
$81,779 |
| TechData Service Company LLC |
Level III |
2 | 2 |
$144,700 |
| TP ICAP Americas Holdings, Inc. |
Level I |
2 | 2 |
$100,000 |
| WAL-MART ASSOCIATES, INC. |
Level III |
2 | 2 |
$240,414 |
| Weill Cornell Medical College |
Level II |
2 | 2 |
$125,785 |
| Admarketplace Inc |
Level III |
1 | 1 |
$165,000 |
| ADP Technology Services, Inc. |
Level IV |
1 | 1 |
$175,781 |
| AFFINITY SOLUTIONS, INC. |
Level III |
1 | 1 |
$155,425 |
| Agenus Inc. |
Level IV |
1 | 1 |
$250,000 |
| Albert Einstein College of Medicine |
Level III |
1 | 1 |
$130,000 |
| Amazon Web Services, Inc. |
Level III |
1 | 10 |
$144,373 |
| American Express Company |
Level II |
1 | 1 |
$130,000 |
| American Express Company |
Level IV |
1 | 1 |
$192,100 |
| American Express Travel Related Services Company, Inc. |
Level II |
1 | 1 |
$128,370 |
| Analysis Group, Inc. |
Level I |
1 | 1 |
$95,000 |
| Ataraxis AI, Inc. |
Level I |
1 | 1 |
$160,000 |
| Axtria INC |
Level IV |
1 | 1 |
$176,000 |
| Balyasny Asset Management, L.P. |
Level II |
1 | 1 |
$250,000 |
| Bankers Healthcare Group LLC |
Level II |
1 | 1 |
$115,000 |
| Barclays Capital Inc. |
Level IV |
1 | 1 |
$220,000 |
| Bayer HealthCare Pharmaceuticals Inc. |
Level IV |
1 | 1 |
$176,000 |
| Bayer Research and Development Services LLC |
Level III |
1 | 1 |
$169,006 |
| BlackRock Financial Management, Inc. |
Level III |
1 | 1 |
$150,000 |
| Blackstone, Inc. |
Level III |
1 | 1 |
$145,000 |
| Bloomberg Index Services Limited |
Level II |
1 | 1 |
$112,965 |
| BNP Paribas Securities Corp. |
Level II |
1 | 1 |
$200,000 |
| Brookhaven National Laboratory |
Level II |
1 | 1 |
$119,995 |
| BTM Capital LLC |
Level II |
1 | 1 |
$114,400 |